|
1
|
Lipinski M, Parks DR, Rouse RV and
Herzenberg LA: Human trophoblast cell-surface antigens defined by
monoclonal antibodies. Proc Natl Acad Sci USA. 78:5147–5150. 1981.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kobayashi H, Minami Y, Anami Y, et al:
Expression of the GA733 gene family and its relationship to
prognosis in pulmonary adenocarcinoma. Virchows Arch. 457:69–76.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muhlmann G, Spizzo G, Gostner J, et al:
TROP2 expression as prognostic marker for gastric carcinoma. J Clin
Pathol. 62:152–158. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang J, Day R, Dong Y, Weintraub SJ and
Michel L: Identification of Trop-2 as an oncogene and an attractive
therapeutic target in colon cancers. Mol Cancer Ther. 7:280–285.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ohmachi T, Tanaka F, Mimori K, Inoue H,
Yanaga K and Mori M: Clinical significance of TROP2 expression in
colorectal cancer. Clin Cancer Res. 12:3057–3063. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fong D, Moser P, Krammel C, et al: High
expression of TROP2 correlates with poor prognosis in pancreatic
cancer. Br J Cancer. 99:1290–1295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bignotti E, Todeschini P, Calza S, et al:
Trop-2 overexpression as an independent marker for poor overall
survival in ovarian carcinoma patients. Eur J Cancer. 46:944–953.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Trerotola M, Rathore S, Goel HL, et al:
CD133, Trop-2 and alpha-2beta1 integrin surface receptors as
markers of putative human prostate cancer stem cells. Am J Transl
Res. 2:135–144. 2010.PubMed/NCBI
|
|
9
|
Fong D, Spizzo G, Gostner JM, et al:
TROP2: a novel prognostic marker in squamous cell carcinoma of the
oral cavity. Mod Pathol. 21:186–191. 2008.PubMed/NCBI
|
|
10
|
Okabe M, Tsukahara Y, Tanaka M, et al:
Potential hepatic stem cells reside in EpCAM+ cells of
normal and injured mouse liver. Development. 136:1951–1960. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goldstein AS, Lawson DA, Cheng D, Sun W,
Garraway IP and Witte ON: Trop2 identifies a subpopulation of
murine and human prostate basal cells with stem cell
characteristics. Proc Natl Acad Sci USA. 105:20882–20887. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ripani E, Sacchetti A, Corda D and Alberti
S: Human Trop-2 is a tumor-associated calcium signal transducer.
Int J Cancer. 76:671–676. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tarnavski O, McMullen JR, Schinke M, Nie
Q, Kong S and Izumo S: Mouse cardiac surgery: comprehensive
techniques for the generation of mouse models of human diseases and
their application for genomic studies. Physiol Genomics.
16:349–360. 2004. View Article : Google Scholar
|
|
14
|
Han Y, Chen JD, Liu ZM, et al: Functional
ion channels in mouse cardiac c-kit(+) cells. Am J Physiol Cell
Physiol. 298:C1109–C1117. 2010.
|
|
15
|
Shimamura A, Ballif BA, Richards SA and
Blenis J: Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr
Biol. 10:127–135. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Roux PP, Richards SA and Blenis J:
Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates
extracellular signal-regulated kinase docking and RSK activity. Mol
Cell Biol. 23:4796–4804. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Alpert JS, Thygesen K, Antman E and
Bassand JP: Myocardial infarction redefined - a consensus document
of The Joint European Society of Cardiology/American College of
Cardiology Committee for the redefinition of myocardial infarction.
J Am Coll Cardiol. 36:959–969. 2000. View Article : Google Scholar
|
|
18
|
Berridge MJ, Lipp P and Bootman MD: The
versatility and universality of calcium signalling. Nat Rev Mol
Cell Biol. 1:11–21. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Petersen BE, Goff JP, Greenberger JS and
Michalopoulos GK: Hepatic oval cells express the hematopoietic stem
cell marker Thy-1 in the rat. Hepatology. 27:433–445. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Anversa P, Kajstura J, Leri A and Bolli R:
Life and death of cardiac stem cells: a paradigm shift in cardiac
biology. Circulation. 113:1451–1463. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Urbanek K, Torella D, Sheikh F, et al:
Myocardial regeneration by activation of multipotent cardiac stem
cells in ischemic heart failure. Proc Natl Acad Sci USA.
102:8692–8697. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Urbanek K, Quaini F, Tasca G, et al:
Intense myocyte formation from cardiac stem cells in human cardiac
hypertrophy. Proc Natl Acad Sci USA. 100:10440–10445. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Levonen AL, Vahakangas E, Koponen JK and
Yla-Herttuala S: Antioxidant gene therapy for cardiovascular
disease: current status and future perspectives. Circulation.
117:2142–2150. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brinckmann M, Kaschina E, Altarche-Xifro
W, et al: Estrogen receptor alpha supports cardiomyocytes
indirectly through post-infarct cardiac c-kit+ cells. J
Mol Cell Cardiol. 47:66–75. 2009. View Article : Google Scholar
|
|
25
|
Altarche-Xifro W, Curato C, Kaschina E, et
al: Cardiac c-kit+AT2+ cell population is
increased in response to ischemic injury and supports cardiomyocyte
performance. Stem Cells. 27:2488–2497. 2009.
|
|
26
|
Padin-Iruegas ME, Misao Y, Davis ME, et
al: Cardiac progenitor cells and biotinylated insulin-like growth
factor-1 nanofibers improve endogenous and exogenous myocardial
regeneration after infarction. Circulation. 120:876–887. 2009.
View Article : Google Scholar
|
|
27
|
Lavu M, Gundewar S and Lefer DJ: Gene
therapy for ischemic heart disease. J Mol Cell Cardiol. 50:742–750.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anjum R and Blenis J: The RSK family of
kinases: emerging roles in cellular signalling. Nat Rev Mol Cell
Biol. 9:747–758. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cubas R, Li M, Chen C and Yao Q: Trop2: a
possible therapeutic target for late stage epithelial carcinomas.
Biochim Biophys Acta. 1796:309–314. 2009.PubMed/NCBI
|
